The 2016 revision of the World Health Organization classification of lymphoid neoplasms, Blood, vol.127, issue.20, pp.2375-2390, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01800015
Immunophenotyping and differential diagnosis of hairy cell leukemia, Hematol Oncol Clin North Am, vol.20, issue.5, pp.1051-1063, 2006. ,
High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairycell leukemias, Nat Genet, vol.46, issue.1, pp.8-10, 2014. ,
Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.26, issue.5, pp.100-107, 2015. ,
Proliférations lymphoïdes B matures à cellules chevelues, Ann Biol Clin, vol.73, issue.4, pp.399-406, 2015. ,
New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes, Oncotarget, vol.9, issue.48, pp.28866-28876, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01929708
BRAF mutations in hairycell leukemia, N Engl J Med, vol.364, issue.24, pp.2305-2315, 2011. ,
Hairy cell leukaemia-variant: disease features and treatment, Best Pract Res Clin Haematol, vol.28, issue.4, pp.253-263, 2015. ,
Recent advances in understanding the biology of marginal zone lymphoma, vol.7, p.406, 2018. ,
Splenic marginal zone lymphoma: prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era, Leuk Res, vol.44, pp.53-60, 2016. ,
Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases ,
, reveals characteristic clinico-pathological features, Haematologica, vol.95, issue.7, pp.1122-1129, 2010.
Splenic diffuse red pulp small B cell lymphoma: toward the emergence of a new lymphoma entity, Discov Med, vol.13, pp.253-265, 2012. ,
A rare case of splenic diffuse red pulp small B-cell lymphoma (SDRPL): a review of the literature on primary splenic lymphoma with hairy cells, Blood Res, vol.53, issue.1, p.71, 2018. ,
Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma, Haematologica, vol.102, issue.10, pp.1758-1766, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01583112
Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations, Blood, vol.129, issue.8, pp.1042-1045, 2017. ,
Cas no 2. Lymphome B de la zone marginale splénique, Ann Pathol, vol.30, issue.3, pp.206-210, 2010. ,
Hairy cell leukemia 2018: update on diagnosis, risk-stratification, and treatment, Am J Hematol, vol.92, issue.12, pp.1382-1390, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02194321
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia, Leukemia, vol.32, issue.8, pp.1768-1777, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02194148
Tyrosine kinase (BTK) and its role in B-cell malignancy, Int Rev Immunol, vol.31, issue.2, pp.119-132, 2012. ,
Targeting Bruton's tyrosine kinase in B cell malignancies, Nat Rev Cancer, vol.14, issue.4, pp.219-232, 2014. ,
The bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach, Br J Haematol, vol.166, issue.2, pp.177-188, 2014. ,
Efficacy and safety of the Bruton tyrosine kinase inhibitor ibrutinib in patients with hairy cell leukemia: stage 1 results of a phase 2 study, Blood, vol.128, issue.22, pp.1215-1215, 2016. ,